[HTML][HTML] Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview

C Chen, JM Lü, Q Yao - Medical science monitor: international …, 2016 - ncbi.nlm.nih.gov
Uric acid is the final oxidation product of purine metabolism in humans. Xanthine
oxidoreductase (XOR) catalyzes oxidative hydroxylation of hypoxanthine to xanthine to uric …

Inhibitors of xanthine oxidase: scaffold diversity and structure‐based drug design

G Luna, AV Dolzhenko, RL Mancera - ChemMedChem, 2019 - Wiley Online Library
Xanthine oxidase (XO) is the enzyme responsible for the catabolism of purines and their
conversion into uric acid. XO is thus the target for the treatment of hyperuricemia and gout …

Xanthine oxidase inhibitors: patent landscape and clinical development (2015–2020)

JV Singh, PMS Bedi, H Singh… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Xanthine oxidase (XO) is a molybdoflavoprotein that catalyzes the oxidative
hydroxylation of purines to produce uric acid and reactive oxygen species. These reaction …

Recent developments of flavonoids with various activities

ZG Sun, ZN Li, JM Zhang, XY Hou… - Current Topics in …, 2022 - ingentaconnect.com
Flavonoids, a series of compounds with a C6-C3-C6 structure, mostly originate from plant
metabolism. Flavonoids have shown beneficial effects on many aspects of human …

Therapeutic effects and mechanisms of N-(9, 10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia

T Gao, J Xu, Y Xiao, J Li, W Hu, X Su, X Shen… - Frontiers in …, 2022 - frontiersin.org
Objective: To observe the antioxidative effects of N-(9, 10-anthraquinone-2-ylcarbonyl)
xanthine oxidase inhibitors (NAY) in vitro and in vivo models of hyperuricemia and explore …

Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.

D Zhou, H Wei, Z Jiang, X Li, K Jiao, X Jia… - Bioorganic & Medicinal …, 2017 - Elsevier
Neuroinflammation is a key contributor to neuronal damage in neurodegenerative diseases.
In our previous work on natural effective neuroinflammatory inhibitors, Alhagi sparsifolia …

Synthesis and Biological Evaluation of Novel Chlorogenic Acid–Apigenin Conjugates as Anti-acute Gout Agents

C Xu, L Li, Z Liu, C Xie, Z Zhai, D Liu, W Liu… - Chemical and …, 2024 - jstage.jst.go.jp
Gout is the second largest metabolic disease worldwide after diabetes, with acute gouty
arthritis as most common symptom. Xanthine oxidase (XOD) and the NOD like receptor-3 …

Research development, optimization and modifications of anti-cancer peptides

ZG Sun, LH Zhao, SM Yeh, ZN Li… - Mini Reviews in …, 2021 - ingentaconnect.com
Anti-cancer peptides play an important role in the area of cancer inhibition. A variety of anti-
cancer peptides have emerged through the extraction and structural modification of peptides …

Study of the reactivity of aminocyanopyrazoles and evaluation of the mitochondrial reductive function of some products

S Bellili, NJ Coltman, NJ Hodges… - Heterocyclic …, 2022 - degruyter.com
This research investigated the general high-throughput synthetic protocol for the accelerated
synthesis of functionalized trifluoromethylpyrazolopyrimidines 3 and N-(5-cyano-3-methyl-1 …

[PDF][PDF] 創薬を志向した多環式芳香族複素環化合物の効率的合成法の開発

加藤淳也, カトウジュンヤ - 2017 - toyaku.repo.nii.ac.jp
1. 緒言多環式芳香族複素環化合物は三環式以上でかつ複素環を一つ以上含む芳香族化合物の
総称であり, π 共役系が延長した平面性の高い構造を有している. また, これら化合物では縮合環 …